Featured Story Using AI to Reduce Delirium in the ICU
Pilot study will explore whether AI headset can help reduce delirium and delay post-delirium cognitive decline.
Pilot study will explore whether AI headset can help reduce delirium and delay post-delirium cognitive decline.
Johns Hopkins psychiatry researcher Andrew Huhn tests the anti-wakefulness medication suvorexant in $18 million clinical trial.
Johns Hopkins researchers will study the connection between PMD and inflammation.